The mice model market expansion is driven by the production and quality control segment owing to the surging demand for mice models for testing the safety of vaccines comprising tuberculosis and malaria vaccine. According to the NBCI (National Center for Biotechnology Information), nearly 15 per cent of the overall animal models, comprising mice are utilized for quality control and vaccine production. The escalating demand for targeted therapy and personalized medicine for the treatment of cancer patients has led to the quality control check and higher production of numerous types of mouse models.

The rising intake of personalized medicines across the globe has also increased the preference for mice model organisms. The National Institute of Aging (NIA), had revealed that humanized mice models are highly utilized in researches for personalized medicines that are used to treat psychological disorders like Alzheimer’s disease.

Get sample copy of this research report @

The annual revenue of the outbred mice model market reached more than USD 1.7 billion in 2019 owing to their higher adoption in transgenic research. The cost-effectiveness and improved fertility offered by outbred mice have increased their preference in comparison to their counterparts. These mice can be easily propagated by implementing non-standardized mating techniques that help to retain their substantial genetic variability.

The application of mice models across production and quality control is poised to rise at a prominent CAGR through 2026. This can be owed to their consistent requirement to inspect the safety of vaccines, particularly for malaria and tuberculosis. There is also an incessant need for personalized medicine and targeted therapies to treat cancer affected individuals. The National Center for Biotechnology Information (NCBI), stated that over 15% of the overall animal models consisting of mice witness high adoption in the production and quality control of vaccines.

One of the recent research trends in the mice model market comprises a study conducted by researchers in Canada and the United States. The study describes the capability of a transgenic mouse model as an effective platform for examining the course of the SARS-CoV-2 infection in humans. As per a lately published report in the journal “Nature Immunology”, the model shares numerous features of COVID-19 in humans and could be essentially utilized for the evaluation of antiviral-based and immunomodulatory drugs.

Brazil registered the highest share for the Latin America mice model market by contributing more than USD 11 million in 2019 on account of the prominent infrastructures and economic growth in the country. The expansion of the research sector across health, biotechnology, and pharmacology has increased the government support towards viral diseases, malaria, leishmaniasis, Chagas, and dengue. For instance, mouse models like CD1 and C57BL6 find extensive application in the study of the Zika virus that has sufficiently affected the regional population.

Prominent players operating in the mice model market comprise Harbour BioMed, Charles River, Envigo, genOway, Taconic Biosciences, Inc., Hera BioLabs, Janvier Labs, and others. These participants are focusing on the implementation of numerous strategic initiatives including product launches, acquisitions, and mergers for maintaining a competitive edge in the mice model market.

Request for a Customization of this research report @

Partial Chapter of the Table of Content

Chapter 4   Mice Model Market, By Mice Type

4.1    Key segment trends

4.2    Inbred

4.2.1    Market size, by region, 2015 – 2026 (USD Million)

4.2.2    Market size, by region, 2015 – 2026 (Units)

4.3    Outbred

4.3.1    Market size, by region, 2015 – 2026 (USD Million)

4.3.2    Market size, by region, 2015 – 2026 (Units)

4.4    Knockout

4.4.1    Market size, by region, 2015 – 2026 (USD Million)

4.4.2    Market size, by region, 2015 – 2026 (Units)

4.5    Hybrid

Chapter 5   Mice Model Market, By Technology

5.1    Key segment trends

5.2    CRISPR

5.2.1    Market size, by region, 2015 – 2026 (USD Million)

5.3    Microinjection

5.3.1    Market size, by region, 2015 – 2026 (USD Million)

5.4    Embryonic Stem Cell Injection

5.4.1    Market size, by region, 2015 – 2026 (USD Million)

5.5    Nuclear Transfer

Browse complete Table of Contents (ToC) of this research report @

Browse Related Reports: -

1. Veterinary Imaging Market Size By Product (Veterinary Imaging Instruments [Radiography (X-ray) Systems, Ultrasound Systems, Computed Tomography Systems, Magnetic Resonance Imaging Systems, Video Endoscopy Imaging Systems, Nuclear Imaging Scanners] Veterinary Software, Veterinary Imaging Reagents [Ultrasound Contrast Reagents, MRI Contrast Reagents, X-Ray/CT Contrast Reagents, Nuclear Imaging Reagents), By Animal Type (Small Companion Animals, Large Animals), By Application (Orthopedics and Traumatology, Oncology, Cardiology, Neurology), By End-use (Hospitals, Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

2.  Capnography Devices Market Size By Product (Hand-held, Stand-alone, Multi-parameter), By Technology (Side Stream, Main Stream, Micro Stream), By Component (Original Equipment Manufacturer (OEM) Modules), By Application (Emergency Medicine, Critical Care, Procedural Sedation, Pain Management), By End-use (Hospitals, Ambulatory Care Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025